Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 13;12(11):1873.
doi: 10.3390/life12111873.

Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free

Affiliations

Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free

Vito Fiore et al. Life (Basel). .

Abstract

Background: People with psychiatric disorders have a high prevalence of HCV. For this reason, tailored interventions should be developed to reach this population.

Methods: We performed a retrospective study on patients treated for HCV infection in psychiatric nursing homes, approached with a quick diagnosis, staging and treatment.

Results: We included data on 586 people screened for HCV with quick tests. High HCV seroprevalence was found in this population (231; 39.4%). Among people who tested positive, there were high rates of active infection (220; 95.2%). Out of the 220 patients with active infection, 95.9% were male, 85.5% were Italian, median age was 43 (IQR = 35-52) years old. In the majority of cases (162; 73.6%), the risk factor was unknown. The most common genotype was 3a (98; 44.5%), and patients mostly had a low fibrosis, according with FIB-4 value (142; 64.5%). Of them, one (0.45%) categorically refused the treatment, and one (0.45%) had liver cirrhosis and advanced hepatocellular carcinoma. Overall, 218 patients underwent eligibility for DAAs. The most prescribed treatment was glecaprevir/pibrentasvir (GLE/PIB (172; 78.2%)). The others practiced sofosbuvir/velpatasvir (SOF/VEL). All patients reached the end of treatment. One (0.45%) was lost to follow up, and all the others reached the SVR12.

Conclusions: The point-of-care testing and pangenotypic DAAs' availability represent one of the most important steps for a fast diagnostic and therapeutical option. Tailored microelimination pathways for every difficult-to-reach/to-treat populations are needed. This would allow us to move more easily towards HCV elimination.

Keywords: DAAs; chronic HCV hepatitis; microelimination programs; psychiatric disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Cascade of care in 220 patients with psychiatric disorders with HCV infection.

Similar articles

Cited by

References

    1. Tohme R.A., Holmberg S.D. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology. 2010;52:1497–1505. doi: 10.1002/hep.23808. - DOI - PubMed
    1. Zaltron S., Spinetti A., Biasi L., Baiguera C., Castelli F. Chronic HCV infection: Epidemiological and clinical relevance. BMC Infect. Dis. 2012;12:S2. doi: 10.1186/1471-2334-12-S2-S2. - DOI - PMC - PubMed
    1. Thomson E.C., Fleming V.M., Main J., Klenerman P., Weber J., Eliahoo J., Smith J., McClure M.O., Karayiannis P. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut. 2011;60:837–845. doi: 10.1136/gut.2010.217166. - DOI - PMC - PubMed
    1. Santantonio T., Wiegand J., Gerlach J.T. Acute hepatitis C: Current status and remaining challenges. J. Hepatol. 2008;49:625–633. doi: 10.1016/j.jhep.2008.07.005. - DOI - PubMed
    1. WHO Hepatitis C factsheets. Switzerland. 2022. [(accessed on 29 September 2022)]. Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.

LinkOut - more resources